<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40436675</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2013-2514</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month></PubDate></JournalIssue><Title>Nefrologia</Title><ISOAbbreviation>Nefrologia (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Improvement in the detection, diagnosis, and early treatment of chronic kidney disease in Spain. The IntERKit project.</ArticleTitle><Pagination><StartPage>351</StartPage><EndPage>359</EndPage><MedlinePgn>351-359</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nefroe.2025.05.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2013-2514(25)00074-4</ELocationID><Abstract><AbstractText>Chronic kidney disease (CKD) is a real public health problem. It is estimated that by 2040, approximately one in five adults will develop CKD, and that by 2050 it will be the third cause of death in Spain. However, CKD is clearly underdiagnosed, with low screening figures in the population at risk, often delaying its identification until advanced stages of the disease, which worsens prognosis and increases associated costs. In addition, drugs are now available that have been shown to reduce the progression of CKD and the risk of developing vascular complications. In this context, the early detection, diagnosis, and initial management of CKD by health organizations should become a priority, as this would reduce the burden of the disease substantially. Since this pathology is oligo, or paucisymptomatic in the initial stages, a proactive attitude is required from the health professional to detect, diagnose, and treat it early. Several publications have shown that, to date, neither the detection of CKD nor its initial management are optimal. The IntERKit project emerged with the aim of improving the early detection, diagnosis, and initial management of CKD by promoting collaboration with health organizations through tools easily implemented by these organizations. The IntERKit project provides healthcare organizations with a structured framework to optimize early management of CKD efficiently, achieving a real, measurable, sustainable, and scalable impact, which can evolve depending on the results obtained.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025. Published by Elsevier Espa&#xf1;a, S.L.U.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>G&#xf3;rriz</LastName><ForeName>Jos&#xe9; Luis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Servicio de Nefrolog&#xed;a, Hospital Cl&#xed;nico Universitario. INCLIVA. Universitat de Val&#xe8;ncia, Valencia, Spain. Electronic address: jlgorriz@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ad&#xe1;n Gil</LastName><ForeName>Fran</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Medicina de Familia y Comunitaria, EAP &#xc9;pila, &#xc9;pila, Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Botana L&#xf3;pez</LastName><ForeName>Manuel A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Secci&#xf3;n de Endocrinolog&#xed;a, Hospital Universitario Lucus Augusti, Lugo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bu&#xf1;o Soto</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de An&#xe1;lisis Cl&#xed;nicos, Hospital Universitario La Paz. IdiPaz. Sociedad Espa&#xf1;ola de Medicina de Laboratorio SEQC(ML), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campos Cabrera</LastName><ForeName>Francisco Jos&#xe9;</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Manager de Crowe Spain - Healthcare, Life Sciences &amp; Social Policy, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cisneros</LastName><ForeName>Angeles</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Vocal de la Sociedad Espa&#xf1;ola de Inform&#xe1;tica de la Salud (SEIS), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cobo Guerrero</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medicina Familiar y Comunitaria, Equipo de Atenci&#xf3;n Primaria La Gavarra, Cornell&#xe0; de Llobregat (Barcelona). Miembro del grupo de trabajo de Enfermedad Renal Cr&#xf3;nica de la Camfic. Miembro del grupo de investigaci&#xf3;n Marcevap del IDIAP Jordi Gol, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conejos</LastName><ForeName>Mar&#xed;a Dolores</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Medicina de Familia. M&#xe1;ster en Gesti&#xf3;n Sociosanitaria. Miembro de la Direcci&#xf3;n T&#xe9;cnica de Procesos y Calidad de la Gerencia Asistencial de Atenci&#xf3;n Primaria de Madrid. Coordinadora del grupo Enfermedad Renal C&#xf3;nica de la Comunidad de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egocheaga Cabello</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Medicina Familiar y Comunitaria, Centro de Salud Universitario Isla de Oza, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez Planelles</LastName><ForeName>M Concepci&#xf3;n</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Direcci&#xf3;n M&#xe9;dica de Atenci&#xf3;n Primaria, Departamento de Alicante-Sant Joan d'Alacant, Alicante, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Matar&#xed;n</LastName><ForeName>Lisardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centro de Salud Aguadulce Sur, Distrito Sanitario Poniente de Almer&#xed;a, Roquetas de Mar, Almer&#xed;a, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Departamento Medical Affairs, Boehringer Ingelheim, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juli&#xe1;n Mauro</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Federaci&#xf3;n Nacional de Asociaciones ALCER. Investigador afiliado, Universidad Aut&#xf3;noma de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le&#xf3;n Jim&#xe9;nez</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Unidad de Riesgo Cardiovascular, Universidad de Sevilla, Hospital Universitario Virgen del Roc&#xed;o, Sevilla, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez Gamote</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Associate Partner de Crowe Spain - Healthcare, Life Sciences &amp; Social Policy, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maz&#xf3;n Ramos</LastName><ForeName>Pilar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servicio de Cardiolog&#xed;a, Hospital Cl&#xed;nico Universitario. CIBERCV, Santiago de Compostela, A Coru&#xf1;a, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortiz</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Nefrolog&#xed;a, Hospital Universitario Fundaci&#xf3;n Jim&#xe9;nez D&#xed;az, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palau</LastName><ForeName>Gemma</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Departamento Market Access, Boehringer Ingelheim, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quevedo Rivera</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Presidenta SEDAP, Sociedad Espa&#xf1;ola de Directivos de Atenci&#xf3;n Primaria, Directora Asistencial M&#xe9;dico. Direcci&#xf3;n Asistencial Este en Gerencia Asistencial de Atenci&#xf3;n Primaria de Madrid, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-&#xc1;lvarez</LastName><ForeName>J Emilio</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Director UGC de Nefrolog&#xed;a, Hospital Universitario Central de Asturias, Oviedo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tristancho Ajamil</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Servicio de la Calidad Asistencial y Sistemas de informaci&#xf3;n. Directora General de Paciente y Cronicidad, Servicio Canario de Salud, Las Palmas de Gran Canaria, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varga Mart&#xed;n</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Enfermer&#xed;a especialista en familiar y comunitaria. Supervisora de &#xe1;rea de integraci&#xf3;n asistencial CHUAC, A Coru&#xf1;a, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vall&#xe9;s Fern&#xe1;ndez</LastName><ForeName>Roser</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Vocal de Catalu&#xf1;a de la Sociedad Espa&#xf1;ola de Farmac&#xe9;uticos de Atenci&#xf3;n Primaria (SEFAP). Jefe Unitat de Farm&#xe0;cia de la Ger&#xe8;ncia Atenci&#xf3; Prim&#xe0;ria i a la Comunitat Barcelon&#xe8;s Nord i Maresme. Institut Catal&#xe0; de la Salut, Badalona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Nefrologia (Engl Ed)</MedlineTA><NlmUniqueID>101778581</NlmUniqueID><ISSNLinking>2013-2514</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="Y">Renal Insufficiency, Chronic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chronic kidney disease</Keyword><Keyword MajorTopicYN="N">Cribado</Keyword><Keyword MajorTopicYN="N">Diagnosis</Keyword><Keyword MajorTopicYN="N">Diagn&#xf3;stico</Keyword><Keyword MajorTopicYN="N">Enfermedad renal cr&#xf3;nica</Keyword><Keyword MajorTopicYN="N">Kidney replacement therapy</Keyword><Keyword MajorTopicYN="N">Screening</Keyword><Keyword MajorTopicYN="N">Tratamiento renal sustitutivo</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors have not received honoraria related to the present manuscript. - Jos&#xe9; Luis G&#xf3;rriz declares funding in relation to clinical trials from AstraZeneca, Bayer, Boehringer Ingelheim, and Novo Nordisk (all to the INCLIVA Research Institute); consulting fees from AstraZeneca, Bayer, Boehringer-Ingelheim, and Novo Nordisk; payment of conference fees from AstraZeneca, Novo Nordisk, Bayer, Menarini, Boehringer-Ingelheim, and Eli Lilly. - Fran Ad&#xe1;n Gil declares no conflicts of interest. - Manuel A. Botana L&#xf3;pez has received consulting fees from AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, Esteve, Roche, Sanofi; fees for presentations, papers, or reports from AstraZeneca, Almirall, Boehringer Ingelheim, Daiichi-Sankyo, Novo Nordisk, Novartis, Lilly, Sanofi, Servier; invitations to congresses, courses, or educational events organized by the pharmaceutical industry, with assistance from AstraZeneca, Boehringer Ingelheim, Lilly, Novo Nordisk, Novartis, Menarini and Sanofi. - Antonio Bu&#xf1;o Soto declares no conflict of interest. - Francisco Jos&#xe9; Campos Cabrera has participated in consulting work for Boehringer-Ingelheim. - &#xc1;ngeles Cisneros declares no conflicts of interest. - Silvia Cobo Guerrero has received fees for conferences from AstraZeneca, GlaxoSmithKline, and Chiesi; for attending symposia, conferences, and training activities for Boehringer-Ingelheim, AstraZeneca, GlaxoSmithKline, Lundbeck, and Chiesi. The author has participated in consensus documents with the support of Boehringer-Ingelheim and AstraZeneca without receiving fees. - Mar&#xed;a Dolores Conejos declares funded attendance at congresses, conferences, and training activities from Boehringer-Ingelheim and Novo Nordisk; fees for participation in congress round tables from Boehringer-Ingelheim. - Isabel Egocheaga Cabello declares having received consulting fees from Bayer, Boehringer-Ingelheim, and Viatris; fees for training activities from AstraZeneca, Rovi, Boehringer-Ingelheim, and Eli Lilly. - M. Concepci&#xf3;n Fern&#xe1;ndez Planelles declares no conflicts of interest. - Lisardo Garc&#xed;a-Matar&#xed;n has received honoraria for conferences from AstraZeneca, Boehringer-Ingelheim, Lilly, Chiesi, GlaxoSmithKline, Bial, Menarini, Teva, Novartis, Pfizer, Sanofi Aventis, FAES, Novo Nordisk, and Vifor Pharma. He has served on advisory boards for Boehringer-Ingelheim, AstraZeneca, Daiichi Sankyo, and GlaxoSmithKline. - Natalia Jim&#xe9;nez is an employee of Boehringer Ingelheim Spain. - Juan Carlos Juli&#xe1;n Mauro states that his organization (ALCER) receives grants that are not related to this project for its participation in advisory boards or for social and health education projects from the following companies: Astellas, AstraZeneca, Baxter, BMS, Boehringer-Ingelheim, CSL Vifor, Diaverum, Fresenius, GSK, Hansa Biopharma, Ipsen, MSD, Novartis, Novonordisk, and Pfizer. - David Le&#xf3;n Jim&#xe9;nez has received speaker fees from AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals Inc., Eli Lilly and Company, Janssen Pharmaceuticals Inc., Mundipharma, Sanofi, Esteve, Novo Nordisk, Mylan (Viatris), Bayer, Novartis, Rovi and Amgen. He has also participated on advisory boards for Sanofi, Boehringer Ingelheim Pharmaceuticals Inc., and Eli Lilly and Company. - Daniel Mart&#xed;nez Gamote has received consulting fees from Boehringer-Ingelheim. - Pilar Maz&#xf3;n Ramos reports participation in conferences/consultancy for AZ, Esteve, Boehringer-Ingelheim, Bayer, BMS-Pfizer, Daichii-Sankyo, Servier, Ferrer, and Novo-Nordisk. - Alberto Ortiz has received grants from Sanofi. He has received consulting fees, speaking fees, and travel support from Adviccene, Alexion, Astellas, AstraZeneca, Amicus, Amgen, Bioporto, Boehringer Ingelheim, Esteve, Fresenius Medical Care, GSK, Bayer, Sanofi-Genzyme, Sobi, Menarini, Mundipharma, Kyowa Kirin, Lilly, Freeline, Idorsia, Chiesi, Otsuka, Novo-Nordisk, Sysmex, and Vifor Fresenius Medical Care, Renal Pharma, and Spafarma, and is Director of the UAM-AstraZeneca Chair in Chronic Kidney Disease and Electrolytes. He owns shares in Telara Farma. - Gemma Palau is an employee of Boehringer Ingelheim Spain. - Julia Quevedo Rivera participated in the consensus document on behalf of Boehringer-Ingelheim. - Emilio S&#xe1;nchez-&#xc1;lvarez declares no conflicts of interest. - Rita Tristancho Ajamilha participated in the consensus document on behalf of Boehringer-Ingelheim. - Cristina Varga declares no conflicts of interest. - Roser Vall&#xe9;s Fern&#xe1;ndez reports funding to attend conferences, workshops, and training activities from Pfizer, Daiichi-Sankyo, and GSK; speaker fees from GSK; and participation in the consensus document on behalf of Boehringer-Ingelheim.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>16</Day><Hour>11</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>29</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>28</Day><Hour>21</Hour><Minute>57</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40436675</ArticleId><ArticleId IdType="doi">10.1016/j.nefroe.2025.05.001</ArticleId><ArticleId IdType="pii">S2013-2514(25)00074-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39368773</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2254-8874</ISSN><JournalIssue CitedMedium="Internet"><Volume>224</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Revista clinica espanola</Title><ISOAbbreviation>Rev Clin Esp (Barc)</ISOAbbreviation></Journal><ArticleTitle>Executive summary of the consensus document on point-of-care ultrasound implementation: recommendations from the Clinical Ultrasound Working Groups of SEMI, SEDAR, SEGG, SEMERGEN, SEMES, SEMFYC, and SEMG.</ArticleTitle><Pagination><StartPage>670</StartPage><EndPage>678</EndPage><MedlinePgn>670-678</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rceng.2024.10.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2254-8874(24)00125-5</ELocationID><Abstract><AbstractText>Point-of-Care Ultrasound has significantly evolved, establishing itself as an essential tool in daily medical practice, especially in various clinical contexts. This consensus document, supported by several Spanish medical societies, proposes guidelines for the effective integration of ultrasound in healthcare, promoting its standardization and ensuring the quality and systematic application of this technique. The working groups, composed of experts from different specialties, conducted a comprehensive review of the literature in MEDLINE and extensively discussed recommendations to formulate a coherent and practical set of guidelines for different application areas: hospital and out-of-hospital emergencies and critical care, primary care, and outpatient hospital care, hospitalization. The methodology included virtual meetings and confidential voting to reach a consensus on the relevant recommendations. Ultrasound was highlighted as fundamental in the initial approach to various pathologies, such as abdominal, thoracic, and musculoskeletal issues, facilitating quick and accurate diagnoses, and reducing the need for unnecessary referrals. Furthermore, this technique has proven valuable in emergencies and critical care, guiding procedures and enhancing the safety and efficiency of clinical interventions. These guidelines not only serve as a framework for clinical practice, education, and research but also aim to ensure that professionals are adequately trained and that ultrasound evaluations are performed to a standard of excellence. The purpose of these recommendations is to standardize and facilitate the adoption of this clinical tool in the daily practice of healthcare, thus improving the quality of the services provided in its various possible applications.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Espa&#xf1;a, S.L.U. and Sociedad Espa&#xf1;ola de Medicina Interna (SEMI). All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tung-Chen</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Hospital Universitario La Paz, Departamento de Medicina, Universidad Aut&#xf3;noma de Madrid, Espa&#xf1;a. Electronic address: yale.tung@salud.madrid.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>representing the 28 collaborators of the SEMI, SEDAR, SEGG, SEMERGEN, SEMES, SEMFYC and SEMG working groups listed in appendix C of this article</CollectiveName><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Hospital Universitario La Paz, Departamento de Medicina, Universidad Aut&#xf3;noma de Madrid, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017065">Practice Guideline</PublicationType><PublicationType UI="D016446">Consensus Development Conference</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Clin Esp (Barc)</MedlineTA><NlmUniqueID>101632437</NlmUniqueID><ISSNLinking>2254-8874</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019095" MajorTopicYN="Y">Point-of-Care Systems</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="Y">Ultrasonography</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Control de calidad en salud</Keyword><Keyword MajorTopicYN="N">Ecograf&#xed;a de urgencias</Keyword><Keyword MajorTopicYN="N">Ecograf&#xed;a en el punto de atenci&#xf3;n</Keyword><Keyword MajorTopicYN="N">Educaci&#xf3;n m&#xe9;dica</Keyword><Keyword MajorTopicYN="N">Emergency ultrasound</Keyword><Keyword MajorTopicYN="N">Healthcare quality assessment</Keyword><Keyword MajorTopicYN="N">Medical education</Keyword><Keyword MajorTopicYN="N">Point-of-care ultrasound</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Tung-Chen</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Coordinador del Grupo de Trabajo de Ecograf&#xed;a Cl&#xed;nica de la SEMI. Servicio de Medicina Interna, Hospital Universitario La Paz, Paseo Castellana 241, 28046, Madrid, Spain.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Short Apellaniz</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Universitario Fundaci&#xf3;n Jim&#xe9;nez D&#xed;az, Madrid. Grupo de Trabajo de Ecograf&#xed;a de SEMFYC.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Alonso Roca</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centro de Salud de Mar B&#xe1;ltico, Madrid. Grupo de Trabajo de Ecograf&#xed;a de SEMFYC.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Alonso Viladot</LastName><ForeName>J R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Servicio de urgencias, Hospital Clinic - Barcelona. Grupo de Trabajo de Ecograf&#xed;a de SEMES.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Arnanz Gonz&#xe1;lez</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Componente del Grupo de Trabajo de Conocimiento en Ecograf&#xed;a de SEMG.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Beltr&#xe1;n Romero</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Hospital Universitario Virgen del Roc&#xed;o. Grupo de trabajo de ecograf&#xed;a SEMI.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Calvo Cebri&#xe1;n</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro de Salud de Robledo de Chavela, Madrid. Grupo de Trabajo de Ecograf&#xed;a de SEMFYC.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Campo Linares</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital de Santa B&#xe1;rbara - Puertollano. Grupo de Trabajo de Ecograf&#xed;a de SEMES.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Foo Gil</LastName><ForeName>K A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Componente del Grupo de Trabajo de Conocimiento en Ecograf&#xed;a SEMG.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Garc&#xed;a Su&#xe1;rez</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Servicio de urgencias, Hospital Universitario San Agust&#xed;n, Avil&#xe9;s. Grupo de Trabajo de Ecograf&#xed;a de SEMES.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Gonz&#xe1;lez Delgado</LastName><ForeName>A D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Servicio de Anestesiolog&#xed;a y Reanimaci&#xf3;n. Cl&#xed;nica Universidad de Navarra, Pamplona. Grupo de Trabajo de Ecograf&#xed;a de SEDAR.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Hern&#xe1;ndez Mart&#xed;nez</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Anestesiolog&#xed;a y Reanimaci&#xf3;n, Hospital Universitari Bellvitge, Barcelona. Grupo de Trabajo de Ecograf&#xed;a de SEDAR.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Marchese Ratti</LastName><ForeName>M F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Coordinador Adjunto del &#xc1;rea de Ecograf&#xed;a SEMG.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mart&#xed;nez Vill&#xe9;n</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Vocal del Grupo de Trabajo de Ecograf&#xed;a de SEMERGEN. Centro de Salud Gandhi Madrid.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mercadal Mercadal</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Anestesiolog&#xed;a, Reanimaci&#xf3;n y Tratamiento del Dolor. Hospital Cl&#xed;nic de Barcelona. Grupo de Trabajo de Ecograf&#xed;a de SEDAR.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Minguela Puras</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Vocal del Grupo de Trabajo de Ecograf&#xed;a de SEMERGEN. Centro de Salud Valle de la Oliva. Majadahonda. Madrid.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Montes Belloso</LastName><ForeName>M E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Coordinadora del Grupo de Trabajo de Ecograf&#xed;a de SEMERGEN. Centro de Salud Isabel II, Parla.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Reinoso P&#xe1;rraga</LastName><ForeName>P P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Servicio de Geriatr&#xed;a, Hospital Universitario La Paz, Madrid. Grupo de Trabajo de Ecograf&#xed;a de SEGG.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Rodr&#xed;guez Urteaga</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Vocal del Grupo de Trabajo de Ecograf&#xed;a de SEMERGEN. Centro de Salud Dos de Mayo, M&#xf3;stoles, Madrid.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Romero Gal&#xe1;n</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Grupo de trabajo de SEMG.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>S&#xe1;nchez Barrancos</LastName><ForeName>I M</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Coordinador del Grupo de Trabajo de Ecograf&#xed;a de la SEMFYC. Centro de Salud P&#xed;o XII, Ciudad Real.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>S&#xe1;nchez Rodr&#xed;guez</LastName><ForeName>J L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Coordinador del grupo de trabajo de Ecograf&#xed;a de la SEGG. Servicio de Geriatr&#xed;a, Hospital de la Sta Creu de Jes&#xfa;s - Tortosa, Tarragona.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>S&#xe1;nchez S&#xe1;nchez</LastName><ForeName>J C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Responsable del &#xe1;rea de Ecograf&#xed;a de la SEMG. Unidad de Radiodiagn&#xf3;stico, Hospital de Poniente, Almer&#xed;a.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Segura Grau</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Direcci&#xf3;n m&#xe9;dica de Centro Diagn&#xf3;stico Ecogr&#xe1;fico. Responsable de la Unidad de Ecograf&#xed;a general del Hospital San Francisco de As&#xed;s en Madrid. Grupo de Trabajo de Ecograf&#xed;a de SEMERGEN.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Torres Macho</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Hospital Universitario Infanta Leonor. Grupo de trabajo de ecograf&#xed;a de la SEMI.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vill&#xe9;n Villegas</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Coordinador del Grupo de Trabajo de Ecograf&#xed;a de la SEMES. Departamento de Medicina, Universidad Francisco de Vitoria, Madrid. Grupo de Trabajo de Ecograf&#xed;a de SEMES.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vives</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Coordinador del grupo de trabajo de ecograf&#xed;a de la SEDAR. Servicio de Anestesiolog&#xed;a y Reanimaci&#xf3;n. Cl&#xed;nica Universidad de Navarra, Pamplona.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Garc&#xed;a de Casasola S&#xe1;nchez</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Servicio de Urgencias, Hospital Universitario Fundaci&#xf3;n de Alcorc&#xf3;n. Grupo de Trabajo de Ecograf&#xed;a de SEMI.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>4</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>5</Day><Hour>19</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39368773</ArticleId><ArticleId IdType="doi">10.1016/j.rceng.2024.10.001</ArticleId><ArticleId IdType="pii">S2254-8874(24)00125-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39034620</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-5851</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Jul</Month><Day>21</Day></PubDate></JournalIssue><Title>Environmental science &amp; technology</Title><ISOAbbreviation>Environ Sci Technol</ISOAbbreviation></Journal><ArticleTitle>Behavioral Responses of Imidacloprid-Dosed Farmland Birds to a Simulated Predation Risk.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.est.4c01893</ELocationID><Abstract><AbstractText>Sublethal exposure to imidacloprid and other neonicotinoid insecticides may affect the neurological functions of birds. As such, behavior may be compromised. Here, we tested experimentally the effects of 1 and 6 mg/kg bw of imidacloprid on the antipredator behavioral responses of the red-legged partridge (<i>Alectoris rufa</i>) to simulated predator threats. Sixty-six partridges were challenged in groups or individually to intra- and interspecific alarm calls, to a raptor silhouette (aerial predation risk), and to a fox model (terrestrial predation risk). Antipredator behaviors were recorded as active (escape, active vigilance) and passive (passive vigilance, crouching, and freezing) responses. Latency in response to the stimuli, percentage of individuals who responded, response duration, speed of active responses, and vocalizations were measured. In experiments with partridges in the group, crouching against simulated predation risk lasted less time in birds treated with 6 mg a.i./kg bw than in control birds. In the experiments with individual partridges, passive vigilance against the intraspecific alarm lasted longer in birds treated with 6 mg a.i./kg bw than in control birds. The observed hyperreactivity to the predatory threat after a sublethal imidacloprid exposure can have consequences on survival under field conditions, where predation is a main driver of population dynamics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Addy-Orduna</LastName><ForeName>Laura M</ForeName><Initials>LM</Initials><Identifier Source="ORCID">0000-0002-2895-686X</Identifier><AffiliationInfo><Affiliation>Instituto Nacional de Tecnolog&#xed;a Agropecuaria (INTA), Estaci&#xf3;n Experimental Agropecuaria Paran&#xe1;, Ruta 11 km 12.5, 3100 Paran&#xe1;, Entre R&#xed;os, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n en Recursos Cineg&#xe9;ticos (IREC), CSIC-UCLM-JCCM, Ronda de Toledo 12, 13005 Ciudad Real, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortiz-Santaliestra</LastName><ForeName>Manuel E</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0001-7102-0496</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n en Recursos Cineg&#xe9;ticos (IREC), CSIC-UCLM-JCCM, Ronda de Toledo 12, 13005 Ciudad Real, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mougeot</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-5819-6275</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n en Recursos Cineg&#xe9;ticos (IREC), CSIC-UCLM-JCCM, Ronda de Toledo 12, 13005 Ciudad Real, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bol&#xed;var-Mu&#xf1;oz</LastName><ForeName>Paula</ForeName><Initials>P</Initials><Identifier Source="ORCID">0009-0008-9668-4000</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n en Recursos Cineg&#xe9;ticos (IREC), CSIC-UCLM-JCCM, Ronda de Toledo 12, 13005 Ciudad Real, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camarero</LastName><ForeName>Pablo R</ForeName><Initials>PR</Initials><Identifier Source="ORCID">0000-0002-2047-6554</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n en Recursos Cineg&#xe9;ticos (IREC), CSIC-UCLM-JCCM, Ronda de Toledo 12, 13005 Ciudad Real, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mateo</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1307-9152</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n en Recursos Cineg&#xe9;ticos (IREC), CSIC-UCLM-JCCM, Ronda de Toledo 12, 13005 Ciudad Real, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Diagn&#xf3;stico Ambiental y Estudios del Agua (IDAEA-CSIC), Jordi Girona 18, 08034 Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Environ Sci Technol</MedlineTA><NlmUniqueID>0213155</NlmUniqueID><ISSNLinking>0013-936X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">birds</Keyword><Keyword MajorTopicYN="N">hyperreactivity</Keyword><Keyword MajorTopicYN="N">neonicotinoid insecticide</Keyword><Keyword MajorTopicYN="N">pesticides</Keyword><Keyword MajorTopicYN="N">stimuli</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>22</Day><Hour>2</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39034620</ArticleId><ArticleId IdType="doi">10.1021/acs.est.4c01893</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38268202</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1439-0531</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Reproduction in domestic animals = Zuchthygiene</Title><ISOAbbreviation>Reprod Domest Anim</ISOAbbreviation></Journal><ArticleTitle>Evaluation of pharmacological alternatives to reduce the pain and discomfort produced by electroejaculation in rams.</ArticleTitle><Pagination><StartPage>e14528</StartPage><MedlinePgn>e14528</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/rda.14528</ELocationID><Abstract><AbstractText>Electroejaculation (EE) represents the main technique for semen collection from domestic and wild animals independently of libido. However, the technique is associated with intense involuntary muscle contractions, vocalization, ataxia and lying down, caused by the electric stimulation of the nerves in the caudal epigastric region. These clinical manifestations represent important indicators of discomfort. In this context, the objective of this study was to evaluate two protocols of local anaesthetic blockade and two anatomical access for pharmacological desensitization of the caudal epigastric innervation as alternatives to promote comfort and reduce stress associated with EE in rams. For the study, four clinically healthy Dorper rams were selected. All animals were subjected to a design consisting of five semen collection treatments (n&#x2009;=&#x2009;3 collections per treatment): T1-control, conventional EE without local anaesthetic blockade; T2, EE with ventral blockade (VB) of epigastric innervation using lidocaine hydrochloride 2%; T3, EE with VB of epigastric innervation using a combination of lidocaine hydrochloride 2% and fentanyl citrate; T4, EE with blockade of epigastric innervation through the perineal access using lidocaine hydrochloride 2%; T5, EE with blockade of epigastric innervation through the perineal access using a combination of lidocaine hydrochloride and fentanyl citrate. Seminal samples resulting from EE were subjectively evaluated for sperm motility and concentration, vigour and volume. Additionally, blood serum samples were collected for quantification of cortisol and creatine kinase (CK) enzyme. Assessments of stress and discomfort were conducted by measuring blood pressure, heart rate (HR) and respiratory rate (RR), as well as observing involuntary muscle contractions, ataxia and animal vocalization. No variations in blood pressure, sperm motility, vigour, CK, and cortisol were observed among the treatments. Individual variations were observed for the occurrence of vocalization (p&#x2009;=&#x2009;.0066), but there were no differences between the groups. Anaesthetic blockades conducted using the combination of lidocaine and fentanyl resulted in a lower incidence of ataxia during EE (p&#x2009;&lt;&#x2009;.0001). It is concluded that the combination of fentanyl citrate and lidocaine hydrochloride results in less discomfort for animals undergoing EE, regardless of the anatomical access used for local anaesthetic blockades.</AbstractText><CopyrightInformation>&#xa9; 2024 Wiley-VCH GmbH. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Mariana Karla Francolino</ForeName><Initials>MKF</Initials><Identifier Source="ORCID">0009-0008-5494-6025</Identifier><AffiliationInfo><Affiliation>Department of Animal Reproduction (VRA), S&#xe3;o Paulo University (USP), S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Santo Amaro University (UNISA), S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Almeida G&#xe9;lio</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Santo Amaro University (UNISA), S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oba</LastName><ForeName>Eunice</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-0333-7437</Identifier><AffiliationInfo><Affiliation>Department of Animal Reproduction, S&#xe3;o Paulo State University (UNESP), Botucatu, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Freitas</LastName><ForeName>Douglas Anderson</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Comprov Diagn&#xf3;stico Veterin&#xe1;rio&#xae;, Valinhos, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>Renata Elisa</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Santos &amp; Green Ltd, Dunedin, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nichi</LastName><ForeName>Marc&#xed;lio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4262-0825</Identifier><AffiliationInfo><Affiliation>Department of Animal Reproduction (VRA), S&#xe3;o Paulo University (USP), S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crespilho</LastName><ForeName>Andr&#xe9; Maciel</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0003-4594-3961</Identifier><AffiliationInfo><Affiliation>Santo Amaro University (UNISA), S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Central Bela Vista (CRV&#xae; Group), Botucatu, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Reprod Domest Anim</MedlineTA><NlmUniqueID>9015668</NlmUniqueID><ISSNLinking>0936-6768</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000779">Anesthetics, Local</NameOfSubstance></Chemical><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance></Chemical><Chemical><RegistryNumber>98PI200987</RegistryNumber><NameOfSubstance UI="D008012">Lidocaine</NameOfSubstance></Chemical><Chemical><RegistryNumber>UF599785JZ</RegistryNumber><NameOfSubstance UI="D005283">Fentanyl</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012756" MajorTopicYN="N">Sheep</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000779" MajorTopicYN="Y">Anesthetics, Local</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013081" MajorTopicYN="N">Sperm Motility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010146" MajorTopicYN="N">Pain</DescriptorName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008012" MajorTopicYN="N">Lidocaine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005283" MajorTopicYN="N">Fentanyl</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001259" MajorTopicYN="N">Ataxia</DescriptorName><QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012757" MajorTopicYN="Y">Sheep Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anaesthetic blockade</Keyword><Keyword MajorTopicYN="N">creatine kinase</Keyword><Keyword MajorTopicYN="N">semen collection</Keyword><Keyword MajorTopicYN="N">stress</Keyword><Keyword MajorTopicYN="N">welfare</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>25</Day><Hour>2</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38268202</ArticleId><ArticleId IdType="doi">10.1111/rda.14528</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Abril-S&#xe1;nchez, S., Crosignani, N., Freitas-de-Melo, A., Terrazas, A., Dami&#xe1;n, J. P., Beracochea, F., Silveira, R., &amp; Ungerfeld, R. (2018). Sedation or anaesthesia decrease the stress response to electroejaculation and improve the quality of the collected semen in goat bucks. Animal, 12(12), 2598-2608.</Citation></Reference><Reference><Citation>Abril-S&#xe1;nchez, S., Freitas-de-Melo, A., Dami&#xe1;n, J. P., Giriboni, J., Villagr&#xe1;-Garc&#xed;a, A., &amp; Ungerfeld, R. (2017). Ejaculation does not contribute to the stress response to electroejaculation in sheep. Reproduction in Domestic Animals, 52(3), 403-408.</Citation></Reference><Reference><Citation>Abril-S&#xe1;nchez, S., Freitas-de-Melo, A., Giriboni, J., Santiano-Moreno, J., &amp; Ungerfeld, R. (2019). Sperm collection by electroejaculation in small ruminants: A review on welfare problems and alternative techniques. Animal Reproduction Science, 205, 1-9.</Citation></Reference><Reference><Citation>Aktas, M., Auguste, D., Lefebvre, H. P., Lefebvre, H. P., Toutain, P. L., &amp; Braun, J. P. (1993). Creatine kinase in the dog: A review. Veterinary Research Communications, 17, 353-369.</Citation></Reference><Reference><Citation>Alonso, M. E., Gonz&#xe1;lez-Monta&#xf1;a, J. R., &amp; Lomillos, J. M. (2020). Consumers' concerns and perceptions of farm animal welfare. Animals, 10(3), 385. https://doi.org/10.3390/ani10030385</Citation></Reference><Reference><Citation>Barros, F. F. P. C., Queiroz, J. P. A. F., Filho, A. C. M., Santos, E. A. A., Paula, V. V., Freitas, C. I. A., &amp; Silva, A. R. (2009). Use of two anesthetic combinations for s&#xea;men collection by electroejaculation from captive coatis (Nasua nasua). Theriogenology, 71(8), 1261-1266.</Citation></Reference><Reference><Citation>Chatdarong, K., Ponglowhapan, S., Manee-in, S., &amp; Pongphet, K. (2006). The use of propofol for electroejaculation in domestic cats. Theriogenology, 66(6-7), 1615-1617.</Citation></Reference><Reference><Citation>Chen, L. M., Hou, R., Zhang, Z. H., Wang, J. S., An, X. R., Chen, Y. F., Zheng, H. P., Xia, G. L., &amp; Zhang, M. J. (2007). Electroejaculation and semen characteristics of Asiatic black bears (Ursus thibetanus). Animal Reproduction Science, 101(3-4), 358-364.</Citation></Reference><Reference><Citation>Col&#xe9;gio Brasileiro de Reprodu&#xe7;&#xe3;o Animal. (2013). Manual para exame androl&#xf3;gico e avalia&#xe7;&#xe3;o de s&#xea;men animal (3rd ed.). CBRA.</Citation></Reference><Reference><Citation>Cunha, M. G. G., Gonzalez, C. I. M., Carvalho, F. F. R., &amp; Soares, A. T. (2012). Effect of diets containing whole cottonseed on the quality of sheep semen. Acta Scientiarum, 34, 305-311.</Citation></Reference><Reference><Citation>Dami&#xe1;n, J. P., &amp; Ungerfeld, R. (2011). The stress response of frequently electroejaculated rams to electroejaculation: Hormonal, physiological, biochemical, haematological and behavioural parameters. Reproduction in Domestic Animals, 46(4), 646-650.</Citation></Reference><Reference><Citation>Fumagalli, F., Dami&#xe1;n, J., &amp; Ungerfeld, R. (2015). Vocalizations during electroejaculation in anaesthetized adult and young pampas deer (Ozotoceros bezoarticus) males. Reproduction in Domestic Animals, 50(2), 321-326.</Citation></Reference><Reference><Citation>Fumagalli, F., Villagr&#xe1;n, M., Dami&#xe1;n, J. P., &amp; Ungerfeld, R. (2012). Physiological and biochemical parameters in response to electroejaculation in adult and yearling anesthetized pampas deer (Ozotoceros bezoarticus) males. Reproduction in Domestic Animals, 47(2), 308-312.</Citation></Reference><Reference><Citation>Madzingira, O. (2018). Animal welfare considerations in food-producing animals. Intech. https://doi.org/10.5772/intechopen.78223</Citation></Reference><Reference><Citation>Manworren, R. C. B. (2015). Multimodal pain management and the future of a personalized medicine approach to pain. AORN Journal, 101(3), 307-318.</Citation></Reference><Reference><Citation>Moreira, S. M., Mendon&#xe7;a F&#xe1;bio, S., Costa, P. T., de Conto, L., Corr&#xea;a, G. F., Schwengber, E. B., Vaz, R. Z., &amp; Silveira, I. D. B. (2017). Carne bovina: Percep&#xe7;&#xf5;es do consumidor frente ao bemestar animal-Revis&#xe3;o de literatura. Revista Electronica de Veterinaria, 18(5), 1-17.</Citation></Reference><Reference><Citation>National Research Council. (2007). Nutrient requirements of small ruminants: Sheep, goats, cervids, and new world camelids. The National Academies Press. https://doi.org/10.17226/11654</Citation></Reference><Reference><Citation>Orihuela, A., Aguirre, A., Hernandez, C., Flores-Perez, I., &amp; Vazquez, R. (2009). Effect of anesthesia on welfare aspects of hair sheep (Ovis aries) during electro-ejaculation. Journal of Animal and Veterinary Advances, 8(2), 305-308.</Citation></Reference><Reference><Citation>Pagliosa, R. C., Derossi, R., Costa, D. S., &amp; Faria, F. J. C. (2015). Efficacy of caudal epidural injection of lidocaine, xylazine and xylazine plus hyaluronidase in reducing discomfort produced by electroejaculation in bulls. Journal of Veterinary Medical Science, 77(11), 1339-1345.</Citation></Reference><Reference><Citation>Palmer, C. W. (2005). Welfare aspects of theriogenology: Investigating alternatives to electroejaculation of bulls. Theriogenology, 64(3), 469-479.</Citation></Reference><Reference><Citation>Romano, J. E., Mari, G., Stradaioli, G., &amp; Mislei, B. (2021). Effect of fasting prior to electroejaculation on behavioral responses and reproductive parameters in young Simmental bulls. Theriogenology, 173, 19-22.</Citation></Reference><Reference><Citation>Santiago-Moreno, J., Toledano-Diaz, A., Sookhthezary, A., G&#xf3;mez-Guillam&#xf3;n, F., Salas de la Vega, R., Pulido-Pastor, A., &amp; L&#xf3;pez-Sebasti&#xe1;n, A. (2011). Effects of anesthetic protocols on electrojaculation variables of Iberian ibex (Capra pyrenaica). Research in Veterinary Science, 90(1), 150-155.</Citation></Reference><Reference><Citation>Semans, J. H., &amp; Langworthy, O. R. (1983). Observations on the neurophysiology of sexual function in the male cat. Journal of Urology, 40(6), 836-846.</Citation></Reference><Reference><Citation>Severo, N. C. (2017). Eletroejacula&#xe7;&#xe3;o e massagem dos genitais internos: Impacto sobre o bem-estar animal. 2&#xaa; Reuni&#xe3;o da Associa&#xe7;&#xe3;o Brasileira de Andrologia Animal (ABRAA), pp. 37-43.</Citation></Reference><Reference><Citation>Ungerfeld, R., Casuriaga, D., Giriboni, J., Freitas-de-Melo, A., Silveira, P., &amp; Brand&#xe3;o, F. Z. (2018). Administration of cloprostenol and oxytocin before electroejaculation in goat bucks reduces the needed amount of electrical stimulation without affecting seminal quality. Theriogenology, 107, 1-5.</Citation></Reference><Reference><Citation>Ungerfeld, R., Fernandes, D. A. M., Balaro, M. F. A., Taira, A. R., Santo, C. G. E., Santos, J. D. R., Costa, M. M. C. P., Carvalho, A. B. S., Rodrigues, A. L. R., &amp; Brand&#xe3;o, F. Z. (2022). Administration of butorphanol with ketamine/xylazine sedation reduces the negative responses to electroejaculation in rams. Theriogenology, 191, 96-101.</Citation></Reference><Reference><Citation>Ungerfeld, R., L&#xf3;pez-Sebasti&#xe1;n, A., Esteso, M., Pradiee, J., Toledano-D&#xed;az, A., Casta&#xf1;o, C., Labrador, B., &amp; Santiago-Moreno, J. (2015). Physiological responses and characteristics of sperm collected after electroejaculation or transrectal ultrasound-guided massage of the accessory sex glands in anesthetizes mouflons (Ovis musimon) and Iberian ibexes (Capra pyrenaica). Theriogenology, 84(7), 1067-1074.</Citation></Reference><Reference><Citation>Ungerfeld, R., Pinto-Santini, L., Chaumont, S., Orihuela, J. C., Guerrero-Gutierrez, M., &amp; Freitas-de-Melo, A. (2021). Is the ram that is more receptive to brushing, less reactive to electroejaculation? Livestock Science, 254, 104764.</Citation></Reference><Reference><Citation>Vidal, F. D., Luz, M. S., Pinho, T. G., &amp; Pissinatti, A. (2007). Coleta de s&#xea;men em mico-le&#xe3;o-de-cara-dourada (Leontopithecus chrysomelas) (Kuhl, 1820) atrav&#xe9;s da eletroejacula&#xe7;&#xe3;o. Revista Brasileira de Ci&#xea;ncia. Veterin&#xe1;ria, 14(2), 67-71.</Citation></Reference><Reference><Citation>Webster, J. (2016). Animal welfare: Freedoms, dominions and &#x201c;a life worth living&#x201d;. Animals, 6(6), 35.</Citation></Reference><Reference><Citation>Whitlock, B. K., Coffman, E. A., Coetzee, J. F., &amp; Daniel, J. A. (2012). Electroejaculation increased vocalization and plasma concentrations of cortisol and progesterone, but not substance P, in beef bulls. Theriogenology, 78(4), 737-746.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32919792</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2341-1929</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Revista espanola de anestesiologia y reanimacion</Title><ISOAbbreviation>Rev Esp Anestesiol Reanim (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Ultrasound diagnosis of a case of transient bilateral vocal cord paralysis secondary to local anesthetic infiltration.</ArticleTitle><Pagination><StartPage>235</StartPage><EndPage>238</EndPage><MedlinePgn>235-238</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.redar.2020.05.021</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0034-9356(20)30184-5</ELocationID><Abstract><AbstractText>One of the most important complications associated with thyroid and parathyroid surgery is vocal cord paralysis due to a recurrent laryngeal nerve injury. Recurrent laryngeal nerve injury paralysis induced by local anesthetics is a rare complication with very few published cases Various techniques are available for diagnosing vocal cord paralysis, including, flexible fiberoptic laryngoscopy, videostrobolaryngoscopy and indirect laryngoscopy. However, these techniques are expensive and are often associated with pain and discomfort among patients. Considering these disadvantages, transcutaneous laryngeal ultrasound is an alternative imaging tool for vocal cord examination in patients undergoing thyroid and parathyroid surgery. We describe a case which was sonographically diagnosed a transient bilateral vocal cord paralysis after the local infiltration of 10mL of 2% mepivacaine administered for the revision of the surgical wound due to a subcutaneous hematoma that occurred after a subtotal parathyroidectomy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Sociedad Espa&#xf1;ola de Anestesiolog&#xed;a, Reanimaci&#xf3;n y Terap&#xe9;utica del Dolor. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mu&#xf1;oz</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servicio de Anestesiolog&#xed;a y Reanimaci&#xf3;n, Hospital Universitari Vall d&#x301;Hebron, Barcelona, Espa&#xf1;a. Electronic address: carlos.munoz@vhebron.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Miguel</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio de Anestesiolog&#xed;a y Reanimaci&#xf3;n, Hospital Universitari Vall d&#x301;Hebron, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rochera</LastName><ForeName>M I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Servicio de Anestesiolog&#xed;a y Reanimaci&#xf3;n, Hospital Universitari Vall d&#x301;Hebron, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dorda</LastName><ForeName>M D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Servicio de Anestesiolog&#xed;a y Reanimaci&#xf3;n, Hospital Universitari Vall d&#x301;Hebron, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caubet</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Servicio de Cirug&#xed;a General, Hospital Universitari Vall d&#x301;Hebron, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez</LastName><ForeName>O</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Servicio de Cirug&#xed;a General, Hospital Universitari Vall d&#x301;Hebron, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Diagn&#xf3;stico ecogr&#xe1;fico de un caso de par&#xe1;lisis bilateral transitoria de las cuerdas vocales secundario a infiltraci&#xf3;n de anest&#xe9;sico local.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Esp Anestesiol Reanim (Engl Ed)</MedlineTA><NlmUniqueID>101778594</NlmUniqueID><ISSNLinking>2341-1929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000779">Anesthetics, Local</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000779" MajorTopicYN="N">Anesthetics, Local</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061226" MajorTopicYN="Y">Recurrent Laryngeal Nerve Injuries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014826" MajorTopicYN="Y">Vocal Cord Paralysis</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014827" MajorTopicYN="N">Vocal Cords</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anest&#xe9;sico local</Keyword><Keyword MajorTopicYN="N">Ecograf&#xed;a</Keyword><Keyword MajorTopicYN="N">Local anesthetics</Keyword><Keyword MajorTopicYN="N">Par&#xe1;lisis de las cuerdas vocales</Keyword><Keyword MajorTopicYN="N">Ultrasonography</Keyword><Keyword MajorTopicYN="N">Vocal cord paralysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>13</Day><Hour>20</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32919792</ArticleId><ArticleId IdType="doi">10.1016/j.redar.2020.05.021</ArticleId><ArticleId IdType="pii">S0034-9356(20)30184-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31791886</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2253-8089</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>Revista espanola de medicina nuclear e imagen molecular</Title><ISOAbbreviation>Rev Esp Med Nucl Imagen Mol (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Clinical applications of nuclear medicine in the diagnosis and assessment of musculoskeletal sports injuries.</ArticleTitle><Pagination><StartPage>112</StartPage><EndPage>134</EndPage><MedlinePgn>112-134</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.remn.2019.09.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2253-654X(19)30281-1</ELocationID><Abstract><AbstractText>Increased participation in sports and physical exercise are widely promoted as an approach to a physically active lifestyle which has a positive effect on healthy aging, in patients and athletes of all ages, beginners and experts, including amateur athletes and professional athletes. Unfortunately, this has caused a higher incidence of sports-related injuries. In the sports context, the early and accurate diagnosis of injuries is of the utmost importance in order to enable early treatment to achieve a full recovery. Imaging techniques are increasingly important for the successful diagnosis and management of the patient. The nuclear medicine techniques with bone tracers provide physiological and metabolic information in the early phases of musculoskeletal injuries, which often precede anatomical changes and they reflect changes in bone turnover. This allows early diagnosis, along with evaluation of the activity and phase of the injury. In this article, the applications of nuclear medicine techniques, focusing on bone scintigraphy, alongside the important contribution of hybrid studies (SPECT/CT), in the diagnosis of bone and soft tissue sports injuries, will be described. In addition, we explain their usefulness in the expression of the pathophysiology of these lesions and their scintigraphic patterns. The article will also describe biomechanical and physiopathological aspects, injury mechanisms and clinical presentations of bone and joint sports injuries, knowledge of this is essential for the correct diagnostic assessment of imaging studies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Sociedad Espa&#xf1;ola de Medicina Nuclear e Imagen Molecular. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Minoves Font</LastName><ForeName>Montse</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cetir-Ascires, Barcelona, Espa&#xf1;a; Vocal del Grupo de Patolog&#xed;a Musculoesquel&#xe9;tica de la SEMNIM, Espa&#xf1;a. Electronic address: mminoves@cetir.es.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Aplicaciones cl&#xed;nicas de la medicina nuclear en el diagn&#xf3;stico y evaluaci&#xf3;n de las lesiones deportivas musculoesquel&#xe9;ticas.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Esp Med Nucl Imagen Mol (Engl Ed)</MedlineTA><NlmUniqueID>101770941</NlmUniqueID><ISSNLinking>2253-8089</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019275">Radiopharmaceuticals</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001168" MajorTopicYN="N">Arthritis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001265" MajorTopicYN="N">Athletic Injuries</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001696" MajorTopicYN="N">Biomechanical Phenomena</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003952" MajorTopicYN="N">Diagnostic Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000070676" MajorTopicYN="N">Enthesopathy</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017102" MajorTopicYN="N">Fracture Healing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071562" MajorTopicYN="N">Fractures, Avulsion</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050723" MajorTopicYN="N">Fractures, Bone</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015775" MajorTopicYN="N">Fractures, Stress</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005599" MajorTopicYN="N">Fractures, Ununited</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072078" MajorTopicYN="N">Positron Emission Tomography Computed Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019275" MajorTopicYN="N">Radiopharmaceuticals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012019" MajorTopicYN="N">Reflex Sympathetic Dystrophy</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072098" MajorTopicYN="N">Single Photon Emission Computed Tomography Computed Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013169" MajorTopicYN="N">Spondylolysis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bone scintigraphy</Keyword><Keyword MajorTopicYN="N">Entesopat&#xed;as</Keyword><Keyword MajorTopicYN="N">Enthesopathies</Keyword><Keyword MajorTopicYN="N">Espondilolisis</Keyword><Keyword MajorTopicYN="N">Fractura de estr&#xe9;s</Keyword><Keyword MajorTopicYN="N">Gammagraf&#xed;a &#xf3;sea</Keyword><Keyword MajorTopicYN="N">Hybrid imaging</Keyword><Keyword MajorTopicYN="N">Imagen h&#xed;brida</Keyword><Keyword MajorTopicYN="N">Impingement syndrome</Keyword><Keyword MajorTopicYN="N">Lesiones osteocondrales</Keyword><Keyword MajorTopicYN="N">Lesi&#xf3;n deportiva</Keyword><Keyword MajorTopicYN="N">Miositis osificante</Keyword><Keyword MajorTopicYN="N">Myositis ossificans</Keyword><Keyword MajorTopicYN="N">Osteochondral lesions</Keyword><Keyword MajorTopicYN="N">SPECT/CT</Keyword><Keyword MajorTopicYN="N">SPECT/TC</Keyword><Keyword MajorTopicYN="N">Spondylolysis</Keyword><Keyword MajorTopicYN="N">Sports injuries</Keyword><Keyword MajorTopicYN="N">Stress fractures</Keyword><Keyword MajorTopicYN="N">S&#xed;ndromes de pinzamiento articular</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31791886</ArticleId><ArticleId IdType="doi">10.1016/j.remn.2019.09.008</ArticleId><ArticleId IdType="pii">S2253-654X(19)30281-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>